Ignite Creation Date:
2025-12-25 @ 3:55 AM
Ignite Modification Date:
2026-03-05 @ 6:04 PM
Study NCT ID:
NCT01957202
Status:
COMPLETED
Last Update Posted:
2017-01-09
First Post:
2013-10-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10
Start Date Type:
None
Primary Completion Date:
2014-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-02
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-04
First Submit QC Date:
None
Study First Post Date:
2013-10-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-10-02
Results First Submit QC Date:
None
Results First Post Date:
2014-10-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-18
Last Update Post Date:
2017-01-09
Last Update Post Date Type:
ESTIMATED